These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 1833900

  • 1. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F, Peters P, Schneider M.
    Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
    [Abstract] [Full Text] [Related]

  • 2. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V, Neuzner J, Opper H, Thormann J, Schlepper M.
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
    Birnbaum DE, Preuner JG, Gieseke R, Kasper-König W, Trenk D, Jähnchen E, Dieterich HA.
    Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897
    [Abstract] [Full Text] [Related]

  • 4. Acute effects of enoximone in chronic heart failure.
    Saborowski F, Peters P, Schneider M, Fehske W, Dieterich HA.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S57-61. PubMed ID: 2480487
    [Abstract] [Full Text] [Related]

  • 5. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
    Holubarsch C, Hasenfuss G, Thierfelder L, Heiss HW, Just H.
    Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
    [Abstract] [Full Text] [Related]

  • 6. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M, Rochiccioli JP, Edouard P, Fourcade J, Massabuau P, Puel J, Fauvel JM, Bounhoure JP.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [Abstract] [Full Text] [Related]

  • 7. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB, Leithe ME, Magorien RD, Unverferth DV, Leier CV.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B, Bouchoucha H, Scholl JM, Hennetier G, Benacerraf A, Achard F, Bock F.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
    [Abstract] [Full Text] [Related]

  • 17. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R, Pucciarelli G, Nocerino L, Cocozza M, Setaro A, Torre G, Imperatore F.
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [Abstract] [Full Text] [Related]

  • 18. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM, Guindo Soldevila J, Rodríguez Font E, Martínez Vílchez R.
    Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.